BYDUREON

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug BYDUREON contains one active pharmaceutical ingredient (API):

1 Exenatide
UNII 9P1872D4OL - EXENATIDE

Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells.

Read about Exenatide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BJ01 Exenatide A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10888C
Country: CA Health Products and Food Branch Identifier(s): 02448610
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1152-MEE-0715
Country: EE Ravimiamet Identifier(s): 1533787, 1533798, 1778902, 1802304
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 111696003
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 088891, 514501
Country: FR Base de données publique des médicaments Identifier(s): 66105532
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 284261, 375913, 380606
Country: HK Department of Health Drug Office Identifier(s): 64579, 66530
Country: IE Health Products Regulatory Authority Identifier(s): 13106, 54347
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7354
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1061235, 1061236, 1076648, 1076649, 1086385, 1088387
Country: NL Z-Index G-Standaard Identifier(s): 16137841
Country: NL Z-Index G-Standaard, PRK Identifier(s): 125636
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 17293
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100252744
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64922001
Country: SG Health Sciences Authority Identifier(s): 15095P
Country: US FDA, National Drug Code Identifier(s): 0310-6530, 0310-6540

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.